Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
ohm20's Profile
Displaying 1401-1450 of 6028 result(s).
CYDY CytoDyn Inc
07/08/2022 11:38:03 PM
Looks like one of those foreign agg
CYDY CytoDyn Inc
07/08/2022 7:19:57 PM
Authorizing new shares is not ideal (18)
CYDY CytoDyn Inc
07/08/2022 6:57:02 PM
That site seems to be blocking me. (2)
CYDY CytoDyn Inc
07/05/2022 5:13:52 PM
Thanks for the heads up. I answered (4)
CYDY CytoDyn Inc
07/05/2022 1:40:05 AM
Sangamon and others gave tried CCR5 (4)
CYDY CytoDyn Inc
07/04/2022 9:18:32 AM
The correct information will keep t (7)
CYDY CytoDyn Inc
07/03/2022 10:18:59 PM
My memory might not be great but it (5)
CYDY CytoDyn Inc
07/03/2022 9:19:49 PM
I don't use the abbreviations. If s (7)
CYDY CytoDyn Inc
07/03/2022 9:05:38 PM
These cells will be targeted and th (1)
CYDY CytoDyn Inc
07/03/2022 8:56:29 PM
LRM increases killing with nitric o (6)
CYDY CytoDyn Inc
07/03/2022 7:17:55 PM
The only one involving HIV cure (fu (1)
CYDY CytoDyn Inc
07/03/2022 6:48:21 PM
Tumor cell irradiation further upr (2)
CYDY CytoDyn Inc
07/03/2022 4:52:49 PM
Leronlimab's downregulation of TNF- (4)
CYDY CytoDyn Inc
07/03/2022 4:13:12 PM
Did anyone understand this?: KOM Sm (2)
CYDY CytoDyn Inc
07/03/2022 3:34:32 PM
Let's just look at one of your clai (3)
CYDY CytoDyn Inc
07/03/2022 2:24:26 PM
Imbeds itself inside a cell"...So w (3)
CYDY CytoDyn Inc
07/02/2022 10:42:39 PM
In a viral reservoir the virus imbe (2)
CYDY CytoDyn Inc
07/02/2022 8:15:17 PM
By any chance are you JLang posting (1)
CYDY CytoDyn Inc
07/02/2022 8:13:56 PM
Not sure where you got 9.85 ms cT1 (6)
CYDY CytoDyn Inc
07/02/2022 6:21:13 PM
A Mean change cT1 - 700 mg group (- (6)
CYDY CytoDyn Inc
07/02/2022 4:51:11 PM
The study involving treatment of le (8)
CYDY CytoDyn Inc
07/02/2022 2:13:00 PM
With the CCR5 delta 32 double mutat (3)
CYDY CytoDyn Inc
07/02/2022 12:56:08 PM
I don't think it is a good idea to (11)
CYDY CytoDyn Inc
07/02/2022 12:11:45 PM
Maybe I am immune to HIV and Covid? (2)
CYDY CytoDyn Inc
07/02/2022 7:42:36 AM
This is nothing really, but its int (9)
CYDY CytoDyn Inc
07/01/2022 4:08:37 PM
Pestell has not been brought on boa (6)
CYDY CytoDyn Inc
07/01/2022 3:58:22 PM
Risankizumab is an IL-23a inhibitor (10)
CYDY CytoDyn Inc
07/01/2022 8:59:55 AM
Excellent paper on neuronal damage (12)
CYDY CytoDyn Inc
07/01/2022 12:07:16 AM
Why is the new president scheduled (8)
CYDY CytoDyn Inc
06/30/2022 4:14:30 PM
Cyrus Arman, PhD, MBA htt (3)
CYDY CytoDyn Inc
06/27/2022 7:44:00 PM
When the Madrigal shareholders are (3)
CYDY CytoDyn Inc
06/27/2022 3:35:29 PM
The low price for Epizyme is due to (12)
CYDY CytoDyn Inc
06/26/2022 8:12:13 PM
Like the Moskva. (3)
CYDY CytoDyn Inc
06/26/2022 1:19:36 AM
Resmetirom reduced MRI-PDFF and LDL (7)
CYDY CytoDyn Inc
06/24/2022 8:39:13 PM
Only when both of these biomarker/l (7)
CYDY CytoDyn Inc
06/24/2022 7:15:31 PM
Leronlimab will have effect through (5)
CYDY CytoDyn Inc
06/24/2022 11:40:30 AM
It only performed good in those wit (10)
CYDY CytoDyn Inc
06/24/2022 9:57:29 AM
It's a good thing Dr. Recknor came (12)
CYDY CytoDyn Inc
06/24/2022 9:55:05 AM
Possibly, we need to assess for the (5)
CYDY CytoDyn Inc
06/24/2022 8:44:53 AM
It could be something as simple as (8)
CYDY CytoDyn Inc
06/24/2022 2:10:55 AM
I heard that Adam Left from Citron (4)
CYDY CytoDyn Inc
06/24/2022 2:07:31 AM
No, leronlimab would have little ef (1)
CYDY CytoDyn Inc
06/23/2022 1:06:58 PM
That would be standard practice. Th (3)
CYDY CytoDyn Inc
06/23/2022 10:06:41 AM
The DSMB would request a halt from (5)
CYDY CytoDyn Inc
06/22/2022 10:20:02 PM
Malice from Amarex needn't be invol (3)
CYDY CytoDyn Inc
06/22/2022 7:46:45 PM
I just glanced through both papers (7)
CYDY CytoDyn Inc
06/22/2022 10:18:46 AM
The multiple and overlapping feedba (12)
CYDY CytoDyn Inc
06/22/2022 3:29:50 AM
The 350mg arm is enough to get a ph (14)
CYDY CytoDyn Inc
06/22/2022 3:08:04 AM
I haven't seen that to be the case (6)
CYDY CytoDyn Inc
06/22/2022 2:56:02 AM
In running through the chemokine pa (7)
Go to page:
  • << First
  • < Previous
  • 28
  • 29
  • Next >

Recent Articles

  • Examining the Acquisition of Guess?, Inc. and Its Implications
  • Investigating Verint Systems: Insights into Shareholder Rights
  • CooperCompanies Reports Strong Q3 Financial Performance
  • NVIDIA Unveils Q2 FY2026 Financial Results and Future Outlook
  • Tilray Brands Meets Nasdaq Compliance with Confidence and Growth
  • CrowdStrike's Stellar Earnings Results and Future Outlook
  • Pure Storage Surges Following Strong Second Quarter Performance
  • Nvidia's Strong Q2 Report: What Investors Need to Know
  • Five Below Stock Upgrades Its Outlook with Stellar Q2 Results
  • NowVertical Group's Financial Performance and Growth Strategies
  • Quorum Information Technologies Sees Growth in Latest Results
  • Golconda Gold Ltd. Posts Strong Q2 Results, Plans New Ventures
  • Celebrating Cultural Bonds at Texas Rangers Friendship Night
  • Aviat Networks CFO Departure and Promising Quarterly Updates
  • Reflecting on Natural Disasters and U.S. Infrastructure Resilience
  • EQB Inc. Appoints Anilisa Sainani as CFO to Drive Growth
  • Unruly Agency Takes Legal Action to Fortify Creator Rights
  • NowVertical Group's Q2 2025 Results Show Stability Amid Changes
  • Tarsus Pharmaceuticals to Engage at Key Investor Events Soon
  • Curanex Pharmaceuticals Completes Initial Public Offering Successfully
  • Class Action Alert: Shareholders of Novo Nordisk A/S (NVO) Lead the Charge
  • Quorum's Impressive Q2 2025 Results Highlight Growth Strategy
  • Understanding the Class Action Lawsuit Against Lineage, Inc.
  • Golconda Gold Ltd. Sees Growth in Second Quarter Results
  • Essential Updates for C3.ai, Inc. Shareholders on Rights
  • Eloro Resources Boosts Private Placement Raising C$11 Million
  • Richtech Robotics: Innovations Driving Stock Surge
  • VEON and Kyivstar Launch Major Campaign in New York
  • Understanding the Legal Actions for RxSight, Inc. Shareholders
  • PARKEN Sport & Entertainment's Optimistic Outlook for 2025
  • Lockheed Martin Corporation Shareholder Alert: Know Your Rights
  • Join the Class Action Suit Against Replimune Group Today
  • Class Action Alert for XPLR Infrastructure LP Investors
  • Major Class Action Alert for Fiserv Inc. Investors Facing Losses
  • Upcoming Conferences Highlight Dycom Industries' Strategy
  • Capricor Therapeutics and Investor Class Action Insights
  • Jasper Therapeutics to Showcase Innovations at Key Conferences
  • Transformative Gains: $100 Investment in Monolithic Power Systems
  • Noah Holdings Expands Investment Horizons with New Fund
  • Centene Corporation Class Action Lawsuit Notification Alert
  • Crucial Information for Tesla, Inc. Shareholders on Rights
  • Bill Holdings Exceeds Expectations with Impressive Q4 Earnings
  • Seeking Justice for KinderCare Learning Investors: Contact Us
  • Legal Actions against Altimmune, Inc. Investors Encouraged to Act
  • Shareholder Rights Update for Unicycive Therapeutics – UNCY
  • Important Steps for Shareholders of Neogen Corporation
  • Upcoming Investor Conferences for Dycom Industries, Inc.
  • Flywire Corporation (FLYW) Faces Class Action Lawsuit for Shareholders
  • Jasper Therapeutics Gears Up for Major Investor Engagement Events
  • Legal Action Against iRobot Corporation: Investor Alert
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site